Cargando…
Chemotherapy directly followed by poly(ADP-ribose) polymerase inhibition as an alternative to surgery in patients with BRCA-mutated ovarian cancer: a potential management strategy in the era of coronavirus disease 2019
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255324/ https://www.ncbi.nlm.nih.gov/pubmed/32454030 http://dx.doi.org/10.1016/j.ajog.2020.05.037 |
| _version_ | 1783539714227175424 |
|---|---|
| author | Vetter, Monica Hagan Smrz, Stacy A. Copeland, Larry J. Cohn, David E. |
| author_facet | Vetter, Monica Hagan Smrz, Stacy A. Copeland, Larry J. Cohn, David E. |
| author_sort | Vetter, Monica Hagan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7255324 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72553242020-05-28 Chemotherapy directly followed by poly(ADP-ribose) polymerase inhibition as an alternative to surgery in patients with BRCA-mutated ovarian cancer: a potential management strategy in the era of coronavirus disease 2019 Vetter, Monica Hagan Smrz, Stacy A. Copeland, Larry J. Cohn, David E. Am J Obstet Gynecol Letter to the Editor Elsevier Inc. 2020-09 2020-05-23 /pmc/articles/PMC7255324/ /pubmed/32454030 http://dx.doi.org/10.1016/j.ajog.2020.05.037 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Vetter, Monica Hagan Smrz, Stacy A. Copeland, Larry J. Cohn, David E. Chemotherapy directly followed by poly(ADP-ribose) polymerase inhibition as an alternative to surgery in patients with BRCA-mutated ovarian cancer: a potential management strategy in the era of coronavirus disease 2019 |
| title | Chemotherapy directly followed by poly(ADP-ribose) polymerase inhibition as an alternative to surgery in patients with BRCA-mutated ovarian cancer: a potential management strategy in the era of coronavirus disease 2019 |
| title_full | Chemotherapy directly followed by poly(ADP-ribose) polymerase inhibition as an alternative to surgery in patients with BRCA-mutated ovarian cancer: a potential management strategy in the era of coronavirus disease 2019 |
| title_fullStr | Chemotherapy directly followed by poly(ADP-ribose) polymerase inhibition as an alternative to surgery in patients with BRCA-mutated ovarian cancer: a potential management strategy in the era of coronavirus disease 2019 |
| title_full_unstemmed | Chemotherapy directly followed by poly(ADP-ribose) polymerase inhibition as an alternative to surgery in patients with BRCA-mutated ovarian cancer: a potential management strategy in the era of coronavirus disease 2019 |
| title_short | Chemotherapy directly followed by poly(ADP-ribose) polymerase inhibition as an alternative to surgery in patients with BRCA-mutated ovarian cancer: a potential management strategy in the era of coronavirus disease 2019 |
| title_sort | chemotherapy directly followed by poly(adp-ribose) polymerase inhibition as an alternative to surgery in patients with brca-mutated ovarian cancer: a potential management strategy in the era of coronavirus disease 2019 |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255324/ https://www.ncbi.nlm.nih.gov/pubmed/32454030 http://dx.doi.org/10.1016/j.ajog.2020.05.037 |
| work_keys_str_mv | AT vettermonicahagan chemotherapydirectlyfollowedbypolyadpribosepolymeraseinhibitionasanalternativetosurgeryinpatientswithbrcamutatedovariancancerapotentialmanagementstrategyintheeraofcoronavirusdisease2019 AT smrzstacya chemotherapydirectlyfollowedbypolyadpribosepolymeraseinhibitionasanalternativetosurgeryinpatientswithbrcamutatedovariancancerapotentialmanagementstrategyintheeraofcoronavirusdisease2019 AT copelandlarryj chemotherapydirectlyfollowedbypolyadpribosepolymeraseinhibitionasanalternativetosurgeryinpatientswithbrcamutatedovariancancerapotentialmanagementstrategyintheeraofcoronavirusdisease2019 AT cohndavide chemotherapydirectlyfollowedbypolyadpribosepolymeraseinhibitionasanalternativetosurgeryinpatientswithbrcamutatedovariancancerapotentialmanagementstrategyintheeraofcoronavirusdisease2019 |